Rosa Torres, PhD

Vanda Pharmaceuticals Inc.
Papers:
FP26-6 Tasimelteon Treatment Entrains the Circadian Clock and Demonstrates a Clinically Meaningful Benefit in Totally Blind Individuals With Non-24-Hour Circadian Rhythms